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Background: The aim of this study is to describe the feasibility and efficacy of the laparoscopic upper vaginectomy
(LUV) in vaginal intraepithelial neoplasia(VAIN) and superficially invasive vaginal carcinoma.
Methods: We studied patients with vaginal intraepithelial neoplasia (VAIN) 2, VAIN 3, and superficially invasive
vaginal carcinoma after hysterectomy who have been under laparoscopic upper vaginectomy between March 2010
and March 2012.
Results: Four patients underwent LUV after hysterectomy for high risk VAIN and early vaginal cancer. The mean
age was 50.8 (range 40–56) years; the mean operation time was 162.5 (range 145–205) minutes; and the mean
estimated blood loss was 55 (range 20–100) ml. All the patients restituted bladder function after the removal of the
foley catheter. Mean hospital stay was 2 days. Two patients had postoperative complications. One patient with
warfarin administration had vaginal stump bleeding and another developed vesico-vaginal fistula. Three of the
patients had no residual lesion, but 1 patient had VAIN 1 in the resection margin. Colposcopy was followed on all
patients and cytology proved no recurrence.
Conclusions: LUV after hysterectomy is a feasible procedure and attentively applicable to high risk VAIN or
superficially invasive vaginal carcinoma.
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Vaginal intraepithelial neoplasia (VAIN) and vaginal carcin-
oma are rare clinical entities. Human papillomavirus infec-
tion, immunosuppression, radiation therapy, and smoking
are reported to be the risk factors [1]. Upper vaginectomy
is a technique applicable to the patients with cervical cancer
after simple hysterectomy, vaginal recurrence of endomet-
rial cancer, vaginal intraepithelial neoplasia, and superfi-
cially invasive vaginal carcinoma. The operation method
has mostly been attempted via the vagina [2-4]. A few stud-
ies have reported using the laparoscopic approach, includ-
ing robotically assisted laparoscopic vaginectomy [2,5,6].* Correspondence: hohoho@catholic.ac.kr
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reproduction in any medium, provided the orHowever, to the best of our knowledge, there has been no
study reporting laparoscopic vaginectomy in VAIN and
superficially invasive vaginal carcinoma following hysterec-
tomy. The aim of this study was to describe the feasibility
and efficacy of laparoscopic vaginectomy in VAIN.Methods
The charts of the patients with VAIN 2, VAIN 3, and
superficial vaginal carcinoma after hysterectomy, who have
undergone laparoscopic vaginectomy between March 2010
and March 2012 were reviewed retrospectively. The patient
details are described in Table 1.
Colposcopy (Carl Zeiss, Inc., Berlin, Germany) was
checked on all the patients to determine the resection area
preoperatively. The lesions were confined to the upper one
third of the vagina (Figure 1A). Under general anesthesia,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of the patients
Patient 1 Patient 2 Patient 3 Patient 4
Age, years 40 56 51 56
Body mass index,
kg/m2
21.78 31.35 25.31 20.13
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HPV human papilloma virus, VAIN vaginal intraepithelial neoplasia.
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and a Foley catheter was inserted. Iodine was applied on
the vagina to confirm the lesion. Then, either a three-ports
or single-port laparoscopic technique was performed. For
the three-ports technique, one 12-mm trocar in the
intraumbilicus and two 5-mm trocars in the lateralFigure 1 Surgical procedures in laparoscopic upper vaginectomy. (A)
a speculum examination. (B) Excision of the stump peritoneum. (C) The vag
rectovaginal spaces through the scar tissue and the isolation of the bladde
edge is restored. (F) The dissected upper vaginal specimen.abdominal walls were used. For the single port technique,
Octoport™ (Dalim surginet, Seoul, Korea) was applied.
The abdomen was explored and adhesiolysis was done to se-
cure an operation field. A rolled gauze grasped by a sponge
forcep was inserted in the vagina and held with gentle up-
ward pressure to keep adequate tension between the vagina
and attendant connective tissues. After opening of visceral
peritoneum over the apex of stump, the vesicovaginal and
rectovaginal spaces were dissected through the scar tissue
and the bladder pillar was isolated (Figure 1B and C). After
the successful separation of the vaginal apex from the blad-
der serosa, a circumferential vaginal incision was performed
and the specimen was removed (Figure 1D). The vaginal
cuff was closed with a running suture using an absorbable
suture (Figure 1E). The bladder was filled with normal saline
to secure the dissected weak point. Supplementary pelvic
lymphadenectomy was performed in the patient with vaginal
cancer (patient 4). The patients were admitted until the gen-
eral condition was recovered. Then, they were scheduled to
visit the gynecologist’s office at 2 weeks after surgery to con-
firm the final diagnosis and plan further management.The planned cutting margin was identified after iodine application via
inal stump at the site of dissection of the vesicovaginal and
r pillar. (D) The resection of the upper vagina. (E) The vaginal cutting
Table 2 Operative data of the patients







Laparoscopic partial upper vaginectomy and
bilateral pelvic lymphadenectomy
Operation time, minutes 150 150 145 205
Estimated blood loss, ml 20 50 50 100




0 5 1 1
Hospital stay, days 3 1 2 2
Final pathology VAIN 3 (positive resection
margin with VAIN 1)
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The mean age was 50.8 (range 40 to 56) years. Three pa-
tients were diagnosed with high-grade VAIN (stage 2 to 3)
and one with early vaginal cancer. Indications for previous
hysterectomy were myoma uteri, carcinoma in situ, and
cervical malignancy (two patients, one patient, and one pa-
tient, respectively) (Table 1). Single port laparoscopy was
performed on one patient and multi-port laparoscopy was
performed on the rest. The mean operation time was
162.5 (range 145 to 205) minutes and the mean estimated
blood loss was 55 (range 20 to 100) ml. One patient had
the Foley catheter removed on the operation day, two on
the postoperative day 1, and one on postoperative day 5.
All the patients restituted bladder function after the re-
moval of the Foley catheter. They were discharged from
hospital before postoperative day 3. Patient 1 had a final
diagnosis of VAIN 3 and the histology confirmed VAIN 1
in the resection margin. Patient 4 had preoperative diagno-
sis of squamous cell carcinoma from the vaginal cytology,
but the final pathological diagnosis from the vaginal stump
was chronic inflammation (Table 2).
Patient 1 had been under administration of warfarin due
to mitral valve regurgitation. Warfarin was replaced by hep-
arin for 3 days and the patient stopped the medication 1
day before the operation. On postoperative day 3, the war-
farin was restarted, however, vaginal bleeding developed on
postoperative day 12. The bleeding stopped after gauzeTable 3 Summary of cases of upper vaginectomy in VAIN 2 to
Authors Number of cases Procedure Com
Indermaur7 105 Upper vaginectomy 10%
Hoffman4 32 Upper vaginectomy 22%
Diakomanolis11 24 Upper vaginectomy Not





vesicpacking. Patient 3 developed a vesicovaginal fistula. It was
not found during the operation even after filling the bladder
with blue-dyed normal saline to check the dissected weak
point. Conservative management was followed; the Foley
catheter was kept in place for 3 months and then the fistula
was spontaneously closed. All patients were followed for 11
to 29 months and colposcopy and cytology proved no
recurrence.
Discussion
Vaginal carcinoma represents 2% to 3% of malignancy of
the female genital tract and VAIN <1% of intraepithelial
neoplasia [7-9]. VAIN 1 regresses spontaneously, therefore
it does not require treatment [10]. For VAIN 2 and 3, no
consensus on the most effective treatment has been
established and various treatment modalities have been pro-
posed, including local excision, partial or total vaginectomy,
radiotherapy, laser vaporization, and topical 5-fluorouracil
administration [11]. Rome et al. grouped 132 VAIN and
early invasive vaginal cancer patients according to different
treatment modalities and reported the long-term follow up
results. The cure rates were 69%, 69%, and 45% when exci-
sion, laser ablation and chemical treatment were performed,
respectively [3]. Radiation may be an efficacious treatment
modality, however, it results in severe adverse effects, in-








mentioned 21% Not mentioned
(1 postopertive bleeding, 1
ovaginal fistula)
0% 0%
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First, it is a treatment modality that provides complete his-
topathologic information, therefore an occult malignancy
is often discovered. When compared to excision, upper
vaginectomy provides whole tissue, not the tissue in pieces
and the lesion is removed in full depth. Moreover, vaginal
lesions are multifocal and a thorough diagnostic evalu-
ation to rule out invasive cancer is difficult; in particular
in patients who have vaginal cuff with distortion post-
hysterectomy, thus making follow up more challenging.
Hoffman et al. reported to have discovered 28% of occult
invasive cancer among 32 patients who underwent upper
vaginectomy for VAIN 3 [4]. Indermaur et al. performed
upper vaginectomy on 105 patients with VAIN and 12%
were diagnosed with occult invasive cancer (Table 3) [7].
Moreover, occult superficially invasive vaginal carcinoma
does not require adjuvant treatment, because previous
studies support upper vaginectomy as an appropriate
treatment [13,14]. Second, it is an effective treatment mo-
dality. Diakomanolis et al. reported that in high-grade
VAIN, upper vaginectomy has a cure rate of 80% while
laser ablation has a 68% cure rate. No recurrence was
found in the current study, where others have reported re-
currence of up to 21% [11]. Third, it is a safe procedure. A
previous study reported that the mean estimated blood
loss was 50 ml and the complication rate was 10%. The
complications were cystotomy, hemorrhagy at the time of
surgery, and wound cellulitis [7]. Our study resulted in 55
(20 to 100) ml of the mean estimated blood loss and one
complication, a vesico-uterine fistula; postoperative bleed-
ing in a patient with warfarin use was reported.
Only four cases are reported here and further studies
with larger numbers of patients should be undertaken
to confirm the data from this pilot study on laparo-
scopic vaginectomy. Moreover, long-term follow-up
indicated support for laparoscopic vaginectomy as a
treatment choice for VAIN and superficially invasive
vaginal carcinoma.
Conclusions
As mentioned previously, this is the first study to report
LUV for post-hysterectomy VAIN and superficially inva-
sive vaginal carcinoma by the laparoscopic approach.
Laparoscopy has an advantage over the conventional ap-
proach in that the clinician can identify the distorted anat-
omy. The method would bring fewer complications,
because the adherence of the bladder and rectum to the
vault, resulting from the previous operation, is more easily
dissected than in the vaginal approach. Moreover, it is an
appropriate modality for patients with vaginal stenosis
from prior therapy or postmenopausal vaginal atrophy.
Though the study has its limitation in the small number of
patients and in surgical and clinical outcomes with rela-
tively short-term follow up, our study suggests thefeasibility and efficacy of the laparoscopic vaginectomy for
the post-hysterectomy patients with VAIN and superfi-
cially invasive vaginal carcinoma.
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